We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+4.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4.96B
AUM Growth
+$180M
(+3.8%)
Cap. Flow
+$9.65M
Cap. Flow
% of AUM
0.19%
Top 10 Holdings %
Top 10 Hldgs %
16.47%
Holding
683
New
65
Increased
262
Reduced
255
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$53M |
| 2 |
Johnson & Johnson
JNJ
|
+$42.8M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$27.6M |
| 4 |
PepsiCo
PEP
|
+$27.5M |
| 5 |
Mastercard
MA
|
+$24.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GMCR
KEURIG GREEN MTN INC
GMCR
|
+$32.8M |
| 2 |
ADT
ADT Corp
ADT
|
+$23.8M |
| 3 |
Cigna
CI
|
+$21.3M |
| 4 |
First Solar
FSLR
|
+$21.3M |
| 5 |
AET
Aetna Inc
AET
|
+$20M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.7% |
| 2 | Financials | 13.24% |
| 3 | Technology | 10.59% |
| 4 | Industrials | 7.94% |
| 5 | Consumer Discretionary | 7.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Estee Lauder
EL
$29.6B
| $3.02M | 0.06% |
36,369
-82,016
| -69% | -$6.46M |
|
327
Canadian Natural Resources
CNQ
$93.6B
| $3M | 0.06% |
202,395
-15,837
| -7% | -$227K |
|
|
AEGR
328
DELISTED
Aegerion Pharmaceuticals
AEGR
| $2.98M | 0.06% |
114,000
+34,000
| +43% | +$865K |
|
|
RLYP
329
DELISTED
RELYPSA INC COM
RLYP
| $2.96M | 0.06% |
82,000
+22,000
| +37% | +$794K |
|
330
SBA Communications
SBAC
$18.4B
| $2.94M | 0.06% |
25,079
-6,018
| -19% | -$710K |
|
|
ANAC
331
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $2.89M | 0.06% |
50,000
-70,000
| -58% | -$2.97M |
|
|
PX
332
DELISTED
Praxair Inc
PX
| $2.89M | 0.06% |
23,899
-26,618
| -53% | -$3.33M |
|
|
DYAX
333
DELISTED
DYAX CORPORATION
DYAX
| $2.85M | 0.06% |
170,000
-110,000
| -39% | -$1.71M |
|
334
Range Resources
RRC
$9.02B
| $2.84M | 0.06% |
54,599
+15,134
| +38% | +$751K |
|
335
Scotiabank
BNS
$106B
| $2.83M | 0.06% |
59,624
+17,297
| +41% | +$845K |
|
336
Alnylam Pharmaceuticals
ALNY
$37.8B
| $2.82M | 0.06% |
27,000
-6,000
| -18% | -$608K |
|
337
US Bancorp
USB
$99.5B
| $2.8M | 0.06% |
64,168
+424
| +0.7% | +$18.6K |
|
338
TC Energy
TRP
$71.4B
| $2.79M | 0.06% |
65,231
-26,288
| -29% | -$1.17M |
|
339
Becton Dickinson
BDX
$44.1B
| $2.73M | 0.06% |
19,492
-5,809
| -23% | -$813K |
|
340
United Parcel Service
UPS
$96.5B
| $2.66M | 0.05% |
27,452
-43,109
| -61% | -$4.42M |
|
341
Target
TGT
$63.6B
| $2.64M | 0.05% |
32,204
-11,200
| -26% | -$865K |
|
342
Leggett & Platt
LEG
$1.52B
| $2.62M | 0.05% |
56,822
-1,234
| -2% | -$55K |
|
|
CTIC
343
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $2.62M | 0.05% |
144,500
+32,000
| +28% | +$720K |
|
344
Simon Property Group
SPG
$74.8B
| $2.61M | 0.05% |
13,345
+450
| +3% | +$87.2K |
|
345
Ovintiv
OVV
$17B
| $2.59M | 0.05% |
46,375
+9,821
| +27% | +$618K |
|
|
XLRN
346
DELISTED
Acceleron Pharma
XLRN
| $2.59M | 0.05% |
68,000
+13,000
| +24% | +$517K |
|
347
Kroger
KR
$35.8B
| $2.57M | 0.05% |
67,102
+10,202
| +18% | +$364K |
|
|
YHOO
348
DELISTED
Yahoo Inc
YHOO
| $2.48M | 0.05% |
55,679
-1,028
| -2% | -$46.5K |
|
|
CMRX
349
DELISTED
Chimerix, Inc.
CMRX
| $2.45M | 0.05% |
65,000
+25,000
| +63% | +$992K |
|
|
EGN
350
DELISTED
Energen
EGN
| $2.45M | 0.05% |
37,059
+7,781
| +27% | +$501K |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q1 2015 Portfolio in Review
As of Q1 2015, Candriam SCA held 683 positions worth $4.96B, up 3.8% from $4.78B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Candriam SCA's Q1 2015 filing shows 65 new, 262 increased, 255 reduced and 50 closed positions. Its largest new stake was TOWERS WATSON & CO COM STK CL A (DE): 96,485 shares worth $12.8M. The largest sale was KEURIG GREEN MTN INC, an estimated $32.8M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 24% a quarter earlier, followed by Financials and Technology.
- Candriam SCA's largest Q1 2015 buy was TOWERS WATSON & CO COM STK CL A (DE): 96,485 shares worth $12.8M.
- Candriam SCA added most to Amgen in Q1 2015, an estimated $53M increase.
- Candriam SCA's biggest Q1 2015 reduction was KEURIG GREEN MTN INC, cutting an estimated $32.8M.
- Candriam SCA fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q1 2015, selling an estimated $19.2M.
- Candriam SCA's ten largest holdings make up 16% of its $4.96B portfolio in Q1 2015.
- Candriam SCA opened 65 new positions and closed 50 in Q1 2015.
- Candriam SCA's portfolio value rose 3.8% quarter-over-quarter to $4.96B.
Based on Candriam SCA's 13F filing for Q1 2015, filed 27 Apr 2015.